2026-525309-11-00招募中1 期
Exploratory, non-randomized, 3-group, microdosing clinical trial to investigate Gallium-68 (68Ga) labeled Platelet-Derived Growth Factor Beta (PDGFRß) targeting Positron Emission Tomography (PET) tracer (68Ga-ATH001) binding in the lungs in healthy participants versus participants with Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD)
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 15
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Lars Johansson
Scientific
Antaros Medical AB
研究点 (2)
Loading locations...
相似试验
已完成
不适用
A clinical study to assess safety, efficacy and in-use tolerability of different dosages of hair growth products in patients with mild to moderate Androgenic Alopecia (Grade I to III).CTRI/2024/08/071884Zywie Ventures Privated Ltd72
尚未招募
1 期
A Phase I Study of PepGNP-ChikV in Healthy VolunteersChikungunyaChikungunya FeverNCT07394426Gylden Pharma Ltd40
尚未招募
不适用
A study to understand the effect of anti-acne medication and overall improvement in patients with severe acne.CTRI/2024/07/070813Sun Pharmaceutical Industries Ltd. (SPIL)300
尚未招募
1 期
Single dose, open-label, laboratory blinded, randomized, 2-treatment, 2-period, 2-sequence, crossover, pivotal study to assess the relative bioavailability of Test Product Naproxen sodium 660 mg modified release tablets to Reference Product Actromadol 660 mg Modified-Release tablets in healthy adult male and female subjects under fed conditions.2025-521732-11-00Laboratorios Cinfa S.A.32
已完成
1 期
Single dose, open-label, laboratory blinded, randomised, 2-treatment, 2-period, 2-sequence, crossover bioequivalence study of test product Perampanel 12 mg film-coated tablets versus reference product Fycompa 12 mg film-coated tablets (Eisai GmbH) in healthy adult male and female subjects under fasting conditions.2023-503345-59-00Laboratorios Cinfa S.A.36